Virtual Grand Rounds
 
Release Date:Friday, August 1, 2014
Expiration Date:Friday, July 31, 2015
Estimated Time To Complete Activity:60 minutes
 

You are invited to participate in this CME-certified virtual grand rounds activity entitled, ”Optimizing Management of Chronic Myelogenous Leukemia: Therapeutic Strategies Making a Difference.”

To participate in this activity, please click on the ‘launch’ button. You will be redirected to RealCME.com.

Fee Statement

There is no fee for this educational activity.

Target Audience

This activity is intended for hematologists/oncologists who treat or manage patients with CML.  The secondary audience is oncology nurses, oncology nurse practitioners, physician assistants, and oncology pharmacists.

Learning Objectives

At the conclusion of this activity, participants should be better able to:

  • Apply mutational testing strategies to inform optimal treatment and monitoring of CML patients
  • Explain and interpret molecular response criteria in CML
  • Identify and define what constitutes poor response, resistant disease, disease intolerance and strategies to overcome these challenges
  • Apply evidence-based updates for selecting optimal treatment for first-line and second- line therapy, including when to consider combination and maintenance options
  • Implement best-practice recommendations for improving patient compliance to oral therapy
  • Evaluate recent trial data on current and novel agents and incorporate newly available treatment options for patients with CML
  • Compare and contrast the safety, tolerability, and clinical outcomes of all options now available for the treatment of patients with CML
Activity Agenda
  • Overview of CML Pathophysiology and Historical Treatment Options
  • Overview of Disease Monitoring & Response to TKI Therapy
  • Mechanisms of Resistant Disease
  • Second-line Treatment and Beyond
  • Best Practices for Patient Adherence
  • Practical Application Cases
Chairperson

Jerald P. Radich, MD Fred Hutchinson Cancer Research Center

Jerald P. Radich, MD
Professor of Medicine
University of Washington School of Medicine
Director of the Molecular Oncology Lab
Fred Hutchinson Cancer Research Center
Seattle, Washington


Peer Reviewer

Amit Verma, MD
Associate Professor, Department of Medicine (Oncology)
Associate Professor, Department of Developmental & Molecular Biology
Albert Einstein College of Medicine
Director, Division of Hematologic Malignancies
Montefiore Medical Center
Bronx, New York
Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center and AXIS Medical Education. Albert Einstein College of Medicine of Yeshiva University is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Albert Einstein College of Medicine of Yeshiva University designates this performance activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

A certificate will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within 3 weeks.

Disclosure of Conflicts of Interest

The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine of Yeshiva University requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical, product, or device company.  Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.

The Albert Einstein College of Medicine of Yeshiva University also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.” Albert Einstein College of Medicine of Yeshiva University, CCME staff, has no conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Technical Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above

For video playback, install the latest version of Flash or Quicktime.

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Provider

Jointly provided by

Albert Einstein College of Medicine and AXIS Medical Education, Inc.

This activity is supported by an educational grant from Bristol-Myers Squibb Company.